<DOC>
	<DOCNO>NCT02111967</DOCNO>
	<brief_summary>In study compare vitamin B12 status measure serum vitamin B12 holotranscobalamin type 2 diabetic patient without metformin treatment . Afterwars investigate biomarker could adequate reflect B12 status metformin-treated patient . With help questionnaire ass clinical , nutritional demographic factor associate vitamin B12 deficiency .</brief_summary>
	<brief_title>Study Identify Adequate Biomarker Detect Vitamin B12 Deficiency Type 2 Diabetic Patients Treated With Metformin</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Vitamin B 12 Deficiency</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Vitamin B 12</mesh_term>
	<mesh_term>Hydroxocobalamin</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>Diagnosis T2DM &gt; 6 month Metformin treatment least 6 month Age &gt; 18 year Ability give write informed consent No metformin treatment last 6 month ( control group ) Concurrent intake preparation contain VB12 ( within last 3 month prior study participation ) Lack write and/or oral understanding German , French , Italian English language Diagnosis Transcobolamin transporter defect Diagnosis Chronic acute liver diseaseliver insufficiency CHILDPUGH score B C acute hepatitis Diagnosis Renal disease ( CreatinineClearance &lt; 60 ml/min ) renal insufficiency stadium III , IV V ( KDOQI ) acute renal disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>